Per management, the new company will have 14 board of directors, with Envision and AmSurg directors sharing equal number of seats, including the top most authority from both the organizations. Benefits of the Deal In terms of financial advantage, this tie-up is expected to boost the new company's adjusted earnings per share in 2017 and by double-digits in 2018. Management also expects to gain synergies worth $100 million within three years of closing the deal, through cost savings and increased revenues.